NO944625L - Substituted N-piperidin-3-pyrazolkarboksamider - Google Patents

Substituted N-piperidin-3-pyrazolkarboksamider

Info

Publication number
NO944625L
NO944625L NO944625A NO944625A NO944625L NO 944625 L NO944625 L NO 944625L NO 944625 A NO944625 A NO 944625A NO 944625 A NO944625 A NO 944625A NO 944625 L NO944625 L NO 944625L
Authority
NO
Norway
Prior art keywords
pyrazolkarboksamider
piperidin
substituted
Prior art date
Application number
NO944625A
Other languages
Norwegian (no)
Other versions
NO304596B1 (en
NO944625D0 (en
Inventor
Francis Barth
Pierre Casellas
Christian Congy
Serge Martinez
Murielle Rinaldi
Gilles Anne Archard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to FR9314444A priority Critical patent/FR2713224B1/en
Priority to FR9408974A priority patent/FR2713225B1/en
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO944625D0 publication Critical patent/NO944625D0/en
Publication of NO944625L publication Critical patent/NO944625L/en
Publication of NO304596B1 publication Critical patent/NO304596B1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26230776&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO944625(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom
NO944625A 1993-12-02 1994-12-01 Substituted N-piperidin-3-pyrazolkarboksamider and pharmaceutica ° ytiske compositions containing these NO304596B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9314444A FR2713224B1 (en) 1993-12-02 1993-12-02 N-piperidino-3-pyrazolecarboxamide substituted.
FR9408974A FR2713225B1 (en) 1993-12-02 1994-07-20 N-piperidino-3-pyrazolecarboxamide substituted.

Publications (3)

Publication Number Publication Date
NO944625D0 NO944625D0 (en) 1994-12-01
NO944625L true NO944625L (en) 1995-06-06
NO304596B1 NO304596B1 (en) 1999-01-18

Family

ID=26230776

Family Applications (2)

Application Number Title Priority Date Filing Date
NO944625A NO304596B1 (en) 1993-12-02 1994-12-01 Substituted N-piperidin-3-pyrazolkarboksamider and pharmaceutica ° ytiske compositions containing these
NO2006010C NO2006010I1 (en) 1993-12-02 2006-08-14 Rimonabtant 5- (p-chlorophenyl) -1- (2,4-dichlorophenyl) -4-methyl-N-piperidinopyrazol-3-carbamide)

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2006010C NO2006010I1 (en) 1993-12-02 2006-08-14 Rimonabtant 5- (p-chlorophenyl) -1- (2,4-dichlorophenyl) -4-methyl-N-piperidinopyrazol-3-carbamide)

Country Status (26)

Country Link
EP (1) EP0656354B1 (en)
JP (2) JP3137222B2 (en)
KR (1) KR100361051B1 (en)
CN (1) CN1047775C (en)
AT (1) AT154012T (en)
AU (1) AU685518B2 (en)
CA (1) CA2136893C (en)
CZ (1) CZ290496B6 (en)
DE (3) DE69403614T2 (en)
DK (1) DK0656354T3 (en)
ES (1) ES2105575T3 (en)
FI (1) FI113647B (en)
FR (1) FR2713225B1 (en)
GR (1) GR3024470T3 (en)
HK (1) HK1000599A1 (en)
HU (1) HU218277B (en)
IL (1) IL111719A (en)
LU (1) LU91268I2 (en)
NL (1) NL300237I2 (en)
NO (2) NO304596B1 (en)
NZ (1) NZ270025A (en)
PL (1) PL180289B1 (en)
RU (1) RU2141479C1 (en)
SG (1) SG68570A1 (en)
SI (1) SI0656354T1 (en)
TW (1) TW282465B (en)

Families Citing this family (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741621B1 (en) * 1995-11-23 1998-02-13 Sanofi Sa New pyrazole derivatives, process for their preparation and pharmaceutical compositions containing
FR2742148B1 (en) * 1995-12-08 1999-10-22 Sanofi Sa New derivatives of pyrazole-3-carboxamide, process for their preparation and pharmaceutical compositions containing them
FR2758723B1 (en) * 1997-01-28 1999-04-23 Sanofi Sa Use of antagonists central cannabinoid receptors for the preparation of medicaments
FR2761266B1 (en) * 1997-03-28 1999-07-02 Sanofi Sa A pharmaceutical composition formed by wet granulation for the oral administration of a derivative of N-piperidino-3-pyrazolecarboxamide, its salts and their solvates
FR2761265B1 (en) * 1997-03-28 1999-07-02 Sanofi Sa A pharmaceutical composition for oral administration of a derivative of N-piperidino-3-pyrazolecarboxamide, its salts and their solvates
AT367809T (en) 1998-04-21 2007-08-15 Us Health Cannabinoids as antioxidants and neuroprotective agent
FR2789079B3 (en) * 1999-02-01 2001-03-02 Sanofi Synthelabo Pyrazolecarboxylic acid derivative, its preparation, pharmaceutical compositions containing
FR2799124B1 (en) * 1999-10-01 2004-08-13 Sanofi Synthelabo Use of antagonists central cannabinoid receptors for the preparation of medicaments
FR2800372B1 (en) * 1999-11-03 2001-12-07 Sanofi Synthelabo tricyclic derivatives 1-benzylpyrazol-3-carboxylic acid, their preparation, medicines containing
FR2804604B1 (en) * 2000-02-09 2005-05-27 Sanofi Synthelabo Use of an antagonist of the central cannabinoid receptors for the preparation of medicaments useful for helping to quit tobacco consumption
WO2001058869A2 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
FR2809621B1 (en) * 2000-05-12 2002-09-06 Sanofi Synthelabo Use of an antagonist of the central cannabinoid receptors for the preparation of medicaments useful as antidiarrhoeal
FR2814678B1 (en) 2000-10-04 2002-12-20 Aventis Pharma Sa Associating a cb1 receptor antagonist and sibutramine, pharmaceutical compositions containing them and their use for the treatment of obesity
US20020091114A1 (en) 2000-10-04 2002-07-11 Odile Piot-Grosjean Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
WO2003007887A2 (en) 2001-07-20 2003-01-30 Merck & Co., Inc. Substituted imidazoles as cannabinoid receptor modulators
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
FR2831883B1 (en) * 2001-11-08 2004-07-23 Sanofi Synthelabo polymorphic form of rimonabant, process for its preparation and pharmaceutical compositions containing
SE0104330D0 (en) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
US7423067B2 (en) 2002-03-26 2008-09-09 Merck & Co., Inc. Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists
FR2837706A1 (en) * 2002-03-28 2003-10-03 Sanofi Synthelabo Using a cannabinoid receptor antagonist cb1 for the preparation of drugs useful for treating sexual dysfunction and / or improve sexual performance
WO2003086288A2 (en) 2002-04-12 2003-10-23 Merck & Co., Inc. Bicyclic amides
US6825209B2 (en) 2002-04-15 2004-11-30 Research Triangle Institute Compounds having unique CB1 receptor binding selectivity and methods for their production and use
US7402835B2 (en) * 2002-07-18 2008-07-22 Chevron U.S.A. Inc. Heteroatom-containing diamondoid transistors
AU2003250106B2 (en) 2002-07-18 2009-11-26 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof
CA2493313C (en) 2002-07-29 2010-03-09 F. Hoffmann-La Roche Ag Novel benzodioxoles
CA2499497A1 (en) 2002-09-27 2004-04-08 Merck & Co., Inc. Substituted pyrimidines
GB0228417D0 (en) * 2002-12-05 2003-01-08 Cancer Rec Tech Ltd Pyrazole compounds
MXPA05007115A (en) 2003-01-02 2005-11-16 Hoffmann La Roche Novel cb 1 receptor inverse agonists.
RU2339618C2 (en) 2003-01-02 2008-11-27 Ф.Хоффманн-Ля Рош Аг Novel reverse agonists of cb1 receptor
AR043633A1 (en) * 2003-03-20 2005-08-03 Schering Corp Cannabinoid receptor ligands
DE10314610A1 (en) 2003-04-01 2004-11-04 Aventis Pharma Deutschland Gmbh New diphenylazetidinone having improved physiological properties, process for its preparation, pharmaceutical compositions containing these compounds and the use thereof
GB0314049D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
EP1641779A1 (en) * 2003-06-18 2006-04-05 AstraZeneca AB 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
AT390922T (en) 2003-06-20 2008-04-15 Hoffmann La Roche 2-aminobenzothiazoles as cb1 receptor inverse agonist
GB0327331D0 (en) * 2003-11-25 2003-12-31 Astrazeneca Ab Therapeutic agents
WO2005058887A1 (en) 2003-12-08 2005-06-30 F. Hoffmann-La Roche Ag Novel thiazole derivates
FR2864958B1 (en) * 2004-01-12 2006-02-24 Sanofi Synthelabo Derivative of N - [(1,5-diphenyl-1H-pyrazol-3-yl) methyl] sulfonamide, their preparation and their therapeutic application.
EP2330124B1 (en) 2005-08-11 2015-02-25 Amylin Pharmaceuticals, LLC Hybrid polypeptides with selectable properties
EP2330125A3 (en) 2005-08-11 2012-12-12 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
EP1574211A1 (en) 2004-03-09 2005-09-14 Inserm Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
CN1950361A (en) 2004-05-10 2007-04-18 霍夫曼-拉罗奇有限公司 Pyrrole or imidazole amides for treating obesity
ITMI20041033A1 (en) 2004-05-24 2004-08-24 Neuroscienze S C A R L pharmaceutical compounds
ITMI20041032A1 (en) 2004-05-24 2004-08-24 Neuroscienze S C A R L pharmaceutical Composites
US8030345B2 (en) 2004-07-12 2011-10-04 Cadila Healthcare Limited Tricyclic pyrazole derivatives as cannabinoid receptor modulators
US20060025448A1 (en) 2004-07-22 2006-02-02 Cadila Healthcare Limited Hair growth stimulators
FR2873372B1 (en) 2004-07-22 2006-09-08 Sanofi Synthelabo A process for preparing derivatives of n-piperidino-1,5-diphenylpyrazole-3-carboxamide
FR2874012B1 (en) * 2004-08-09 2008-08-22 Sanofi Synthelabo Pyrrole derivatives, their preparation and their therapeutic in wasch
AT399156T (en) 2004-10-27 2008-07-15 Hoffmann La Roche New indole or benzimidazole derivatives
US8394765B2 (en) 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
AT427759T (en) 2004-11-01 2009-04-15 Amylin Pharmaceuticals Inc Treatment of obesity and associated diseases
DE602005024430D1 (en) 2004-11-09 2010-12-09 Hoffmann La Roche Dibenzosuberone derivatives
EP1820504A1 (en) * 2004-11-15 2007-08-22 Taisho Pharmaceutical Co., Ltd Imine compound
FR2880023B1 (en) 2004-12-23 2007-02-23 Sanofi Aventis Sa Derived from N - [(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine their preparation and their application in therapeutic
BRPI0606199A2 (en) * 2005-01-06 2009-11-17 Cadila Healthcare Ltd hydrochloride, rimonabant process for the preparation of a hydrochloride of rimonabant, pharmaceutical composition, pharmaceutical dosage form, use of Rimonabant hydrochloride and a method of treatment
US8853205B2 (en) 2005-01-10 2014-10-07 University Of Connecticut Heteropyrrole analogs acting on cannabinoid receptors
JP2008526887A (en) * 2005-01-10 2008-07-24 ユニバーシティ オブ コネチカット The novel hetero-pyrrole analogs that act on cannabinoid receptors
FR2881744B1 (en) 2005-02-09 2007-04-27 Sanofi Aventis Sa Derived from N - [(4,5-diphenyl-2-thienyl) methyl] amine, their preparation and their application in therapeutic
FR2882262B1 (en) * 2005-02-23 2007-04-06 Sanofi Aventis Sa Use of a pyrazole derivative for the preparation of medicaments useful in prevention and treatment of kidney disease
FR2882263B1 (en) * 2005-02-23 2007-04-06 Sanofi Aventis Sa Use of a pyrazole derivative for the preparation of medicaments useful in prevention and treatment of kidney disease
DE102005011050A1 (en) 2005-03-10 2006-09-21 Degussa Ag A process for the preparation of 1-aminopiperidine derivatives
WO2006106054A1 (en) 2005-04-06 2006-10-12 F. Hoffmann-La Roche Ag Pyridine-3-carboxamide derivatives as cb1 inverse agonists
CN1310891C (en) * 2005-05-19 2007-04-18 金鑫 N-piperidino-1-(2,4-dichlorophenyl)-4-methyl-5-(4-chlorophenyl)pyrazole-3-formamide organic salts and their pharmaceutical compositions
DE102005026762A1 (en) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-one derivatives as inhibitors of lipases, and phospholipases
MX2007016508A (en) 2005-06-30 2008-03-04 Prosidion Ltd Gpcr agonists.
FR2888236B1 (en) * 2005-07-08 2007-09-21 Sanofi Aventis Sa Derived from N - [(1,5-diphenyl-1H-pyrazol-3-yl) methyl] sulfonamide, their preparation and their application in therapeutic
EP1743637A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
GB0514739D0 (en) * 2005-07-19 2005-08-24 Astrazeneca Ab Therapeutic agents
EP1752149A1 (en) 2005-07-29 2007-02-14 Laboratorios Del Dr. Esteve, S.A. CB1 Antagonists or inverse agonists as therapeutical agents for the treatment of inflammation involving gene expression
WO2007041052A2 (en) 2005-09-29 2007-04-12 Merck & Co., Inc. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
JP5069894B2 (en) * 2005-10-21 2012-11-07 田辺三菱製薬株式会社 Pyrazole compound
CN100999517B (en) 2006-01-11 2010-12-15 北京摩力克科技有限公司 Pyrazole formylamine derivate, its pharmaceutical composition and preparation process
EP1816125A1 (en) * 2006-02-02 2007-08-08 Ranbaxy Laboratories, Ltd. Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
FR2897060B1 (en) * 2006-02-08 2008-07-25 Sanofi Aventis Sa The rimonabant monohydrate, process for its preparation and pharmaceutical compositions containing
WO2007121687A1 (en) * 2006-04-26 2007-11-01 Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China 4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament
CN101062919B (en) 2006-04-26 2012-08-15 中国人民解放军军事医学科学院毒物药物研究所 4-methyl-1H-diaryl pyrromonazole derivative and medicament usage thereof
FR2902008A1 (en) * 2006-06-07 2007-12-14 Sanofi Aventis Sa Use of an antagonist of the CB1 cannabinoid receptors for the preparation of medicaments useful for the prevention and treatment of benign prostatic hypertrophy
US7629346B2 (en) 2006-06-19 2009-12-08 Hoffmann-La Roche Inc. Pyrazinecarboxamide derivatives as CB1 antagonists
WO2008038143A2 (en) * 2006-06-22 2008-04-03 Medichem, S.A. Novel solid forms of rimonabant and synthetic processes for their preparation
DE602007003024D1 (en) 2006-06-27 2009-12-10 Sandoz Ag New method for salt production
US7297710B1 (en) 2006-07-12 2007-11-20 Sanofi-Aventis Derivatives of N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide, their preparation and their application in therapeutics
MX2009001043A (en) 2006-08-08 2009-02-06 Sanofi Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use.
WO2008026219A2 (en) * 2006-09-01 2008-03-06 Hetero Drugs Limited Novel polymorphs of rimonabant
US7781593B2 (en) 2006-09-14 2010-08-24 Hoffmann-La Roche Inc. 5-phenyl-nicotinamide derivatives
WO2008035023A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Polymorphs of rimonabant
US8173629B2 (en) 2006-09-22 2012-05-08 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
WO2008056377A2 (en) * 2006-11-06 2008-05-15 Cadila Healthcare Limited Polymorphic forms of rimonabant
FR2909090B1 (en) 2006-11-23 2009-01-09 Sanofi Aventis Sa Derivatives of 2,5-dihydro-3H-pyrazolo [4,3-c] pyridazin-3-one derivatives, their preparation and their therapeutic application.
CZ300115B6 (en) * 2006-12-01 2009-02-11 Zentiva, A. S. Process for preparing N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (rimonabant)
WO2008064615A2 (en) * 2006-12-01 2008-06-05 Zentiva, A.S. Crystalline and amorphous forms of rimonabant and processes for obtaining them
AR064735A1 (en) 2007-01-04 2009-04-22 Prosidion Ltd GPCR agonists and pharmaceutical composition based on the compound
WO2008081204A1 (en) 2007-01-04 2008-07-10 Prosidion Limited Piperidine gpcr agonists
GB0700122D0 (en) 2007-01-04 2007-02-14 Prosidion Ltd GPCR agonists
AR064736A1 (en) 2007-01-04 2009-04-22 Prosidion Ltd GPCR agonists
BRPI0806312A2 (en) 2007-01-04 2011-09-06 Prosidion Ltd CGRP agonists piperidine
FR2911136B1 (en) 2007-01-05 2009-02-20 Sanofi Aventis Sa Derivatives of N- (4-cyano-1H-pyrazol-3-yl) methylamine substituted their preparation and their therapeutic application.
US20080182877A1 (en) * 2007-01-05 2008-07-31 Westheim Raymond J H Rimonabant forms and methods of making the same
EP1944297A1 (en) * 2007-01-09 2008-07-16 Miklós Vértessy Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof
EP1953144A1 (en) 2007-01-30 2008-08-06 Sandoz AG Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide
US8431609B2 (en) 2007-02-19 2013-04-30 Darmesh Mahendrabhai Shah Process for preparation of pyrazole derivatives
WO2008101860A1 (en) * 2007-02-20 2008-08-28 Sandoz Ag Novel process for the preparation of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-n-(piperidin-1-yl)pyrazole-3-carboxamide
FR2913018A1 (en) * 2007-02-23 2008-08-29 Sanofi Aventis Sa New pyrazol-3-carboxamide derivative in amorphous form comprising surinabant and rimonabant form, useful for preparing amorphous solid solution
EP2145884B1 (en) 2007-04-02 2014-08-06 Msd K.K. Indoledione derivative
JP4994295B2 (en) * 2007-04-20 2012-08-08 田辺三菱製薬株式会社 Pharmaceutical compositions
CN101302200B (en) 2007-05-09 2011-04-20 上海医药工业研究院 Preparation of N-piperidine subbase-5-(4-chlorphenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-formamide
CN100560582C (en) 2007-07-26 2009-11-18 上海佰瑞生物科技有限公司 Piperidinopyrazoles compound and its preparation method and application
FR2919184A1 (en) * 2007-07-26 2009-01-30 Sanofi Aventis Sa Use of 5-(4-chlorophennyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid as a medicament for treating e.g. chronic pain, neuropathic pain, inflammation, benign hypertrophy of the prostate and diabetic neuropathy
FR2919866A1 (en) * 2007-08-06 2009-02-13 Sanofi Aventis Sa The methanol solvate of rimonabant, process for its preparation and pharmaceutical compositions containing
FR2919867A1 (en) * 2007-08-06 2009-02-13 Sanofi Aventis Sa The solvate of 2-methoxyethanol rimonabant and method of preparing
FR2919863A1 (en) * 2007-08-06 2009-02-13 Sanofi Aventis Sa The solvate n-methylpyrrolidone rimonabant, process for its preparation and pharmaceutical compositions containing
FR2919861A1 (en) * 2007-08-06 2009-02-13 Sanofi Aventis Sa The solvate of isopranol rimonabant, process for its preparation and pharmaceutical compositions containing
FR2919868A1 (en) * 2007-08-06 2009-02-13 Sanofi Aventis Sa The solvate n, n-dimethylformamide rimonabant, and its method of preparing
FR2919865A1 (en) * 2007-08-06 2009-02-13 Sanofi Aventis Sa The DMSO solvate of rimonabant, process for its preparation and pharmaceutical compositions containing
FR2919862A1 (en) * 2007-08-06 2009-02-13 Sanofi Aventis Sa The solvate of 3-methylbutan-1-ol of rimonabant, process for its preparation and pharmaceutical compositions containing
FR2919864A1 (en) * 2007-08-06 2009-02-13 Sanofi Aventis Sa The 1,4-dioxane solvate of rimonabant, process for its preparation and pharmaceutical compositions containing
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
DE102007063671A1 (en) 2007-11-13 2009-06-25 Sanofi-Aventis Deutschland Gmbh , Pharmaceuticals novel crystalline Diphenylazetidinonhydrate containing these compounds and their use
WO2009109222A1 (en) * 2008-03-04 2009-09-11 Maprimed, S. A. Process for the preparation of rimonabant
WO2009153804A1 (en) * 2008-06-16 2009-12-23 Cadila Healthcare Limited Process for preparing form i of rimonabant
AR072707A1 (en) 2008-07-09 2010-09-15 Sanofi Aventis heterocyclic compounds, processes for their preparation, medicaments comprising these compounds and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
WO2010079241A1 (en) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Use of antagonists and/or inverse agonists of cb1 receptors for the preparation of drugs that increase motor neuron excitability
US10053444B2 (en) 2009-02-19 2018-08-21 University Of Connecticut Cannabinergic nitrate esters and related analogs
MX2012001729A (en) 2009-08-26 2012-06-13 Sanofi Sa Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use.
WO2011157827A1 (en) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8410107B2 (en) 2010-10-15 2013-04-02 Hoffmann-La Roche Inc. N-pyridin-3-yl or N-pyrazin-2-yl carboxamides
US8669254B2 (en) 2010-12-15 2014-03-11 Hoffman-La Roche Inc. Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2683705B1 (en) 2011-03-08 2015-04-22 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683701B1 (en) 2011-03-08 2014-12-24 Sanofi Oxathiazine derivatives substituted with benzyl or heteromethylene groups, method for their preparation, their usage as medicament, medicament containing same and its use
WO2012120057A1 (en) 2011-03-08 2012-09-13 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120050A1 (en) 2011-03-08 2012-09-13 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683698B1 (en) 2011-03-08 2017-10-04 Sanofi Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120053A1 (en) 2011-03-08 2012-09-13 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
CN102206182B (en) * 2011-04-11 2013-03-13 中国药科大学 Method for synthesizing Rimonabant hydrochloride
AR087701A1 (en) 2011-08-31 2014-04-09 Japan Tobacco Inc Pyrazole derivatives with inhibitory activity of SGLT1
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US8962845B2 (en) * 2011-09-30 2015-02-24 National Health Research Institutes Pyrazole compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449350A (en) * 1968-06-24 1969-06-10 Ciba Geigy Corp Certain pyrazole-3-carboxylic acid hydrazide derivatives
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
FR2665898B1 (en) * 1990-08-20 1994-03-11 Sanofi Amide derivatives of 3-pyrazole, process for their preparation and pharmaceutical compositions containing them.
FR2692575B1 (en) * 1992-06-23 1995-06-30 Sanofi Elf New pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them.

Also Published As

Publication number Publication date
DE69403614D1 (en) 1997-07-10
JP3137222B2 (en) 2001-02-19
CA2136893A1 (en) 1995-06-21
CA2136893C (en) 2002-06-25
DE122006000034I1 (en) 2006-11-23
NL300237I1 (en) 2006-10-02
AU7899994A (en) 1995-06-15
JP3995405B2 (en) 2007-10-24
GR3024470T3 (en) 1997-11-28
FI945690D0 (en)
AU685518B2 (en) 1998-01-22
RU94042232A (en) 1996-10-10
EP0656354A1 (en) 1995-06-07
DK0656354T3 (en) 1997-12-29
IL111719D0 (en) 1995-01-24
IL111719A (en) 1999-10-28
CZ290496B6 (en) 2002-08-14
LU91268I2 (en) 2006-09-26
DE69403614T2 (en) 1998-01-22
RU2141479C1 (en) 1999-11-20
JP2001026541A (en) 2001-01-30
FI945690A0 (en) 1994-12-02
PL180289B1 (en) 2001-01-31
EP0656354B1 (en) 1997-06-04
FR2713225A1 (en) 1995-06-09
KR100361051B1 (en) 2005-08-10
AT154012T (en) 1997-06-15
SG68570A1 (en) 2000-06-20
LU91268A9 (en)
DK656354T3 (en)
CZ301694A3 (en) 1995-06-14
TW282465B (en) 1996-08-01
PL306067A1 (en) 1995-06-12
HK1000599A1 (en) 1998-04-09
SI0656354T1 (en) 1997-10-31
FI945690A (en) 1995-06-03
HU9403471D0 (en) 1995-02-28
NO2006010I1 (en) 2006-08-28
JPH07309841A (en) 1995-11-28
ES2105575T3 (en) 1997-10-16
FR2713225B1 (en) 1996-03-01
HU218277B (en) 2000-07-28
FI113647B (en) 2004-05-31
CN1047775C (en) 1999-12-29
NZ270025A (en) 1995-09-26
NO304596B1 (en) 1999-01-18
CN1110968A (en) 1995-11-01
NO944625D0 (en) 1994-12-01
NL300237I2 (en) 2006-11-01
FI113647B1 (en)
KR950017988A (en) 1995-07-22
HUT71498A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
DE10299013I2 (en) Aza-Zyklohexapeptide
AT282366T (en) Wirbeldistraktor
AT186056T (en) Fliessbettpolymerisationsreaktor
AT159176T (en) Pleuradrainagevorrichtung
AT204141T (en) Schuhsohlekomponent
AT154012T (en) n-piperidin-3-substituted pyrazolecarboxamide
AT281812T (en) Hydrogelwundverband
AT138384T (en) Olionukleotidalkylphosphonate and - phosphonothioate
AT182420T (en) Sprachaktivitaetsdetektor
AT188809T (en) Festoxidbrennstoffzellenstrukturen
AT237390T (en) Fibrinogenextraktion
AT156215T (en) Kautschukleitwand
AT200872T (en) Abrasivstrahlströmungsschneider
AT235555T (en) Aspertokinasegenvarianten
AT178362T (en) Sanitaereinrichtungen
AT194639T (en) Zelluloseesterzusammensetzungen
AT160711T (en) Beulversteifung
AT144808T (en) Saugbagger
NO942091L (en) Inside tilpasningssko
AT185898T (en) Gaskartousche
AT184112T (en) Kamerafuhrungssystem
NO940038D0 (en) Arylsulfonamido-substituted hydrokamsyrer
NO954071D0 (en) Innkapslingssammensetninger
NO961382D0 (en) HIV - protease - inhibitors
NO942237D0 (en) Sportsstövel

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: ACOMPLIA; NAT. REG. NO/DATE: EU106344001 20060619; FIRST REG. NO/DATE: EU , 726/2004 20060619

Spc suppl protection certif: 2006010

Filing date: 20060814

MM1K Lapsed by not paying the annual fees